Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity.

Santangelo G, Corte MD, Sparaco M, Miele G, Garramone F, Cropano M, Esposito S, Lavorgna L, Gallo A, Tedeschi G, Bonavita S.

Acta Neurol Belg. 2019 Sep 30. doi: 10.1007/s13760-019-01212-5. [Epub ahead of print]

PMID:
31571134
2.

Subretinal Fibrosis in Stargardt's Disease with Fundus Flavimaculatus and ABCA4 Gene Mutation.

Rossi S, Testa F, Attanasio M, Orrico A, de Benedictis A, Corte MD, Simonelli F.

Case Rep Ophthalmol. 2012 Sep;3(3):410-7. doi: 10.1159/000345415. Epub 2012 Dec 20.

3.

The role of optical coherence tomography in an atypical case of oculocutaneous albinism: a case report.

Rossi S, Testa F, Gargiulo A, Di Iorio V, Pierri RB, D'Alterio FM, Corte MD, Surace E, Simonelli F.

Case Rep Ophthalmol. 2012 Jan;3(1):113-7. doi: 10.1159/000337489. Epub 2012 Mar 27.

4.

MicroRNA-restricted transgene expression in the retina.

Karali M, Manfredi A, Puppo A, Marrocco E, Gargiulo A, Allocca M, Corte MD, Rossi S, Giunti M, Bacci ML, Simonelli F, Surace EM, Banfi S, Auricchio A.

PLoS One. 2011;6(7):e22166. doi: 10.1371/journal.pone.0022166. Epub 2011 Jul 26.

5.

An atypical form of Bietti crystalline dystrophy.

Rossi S, Testa F, Li A, Iorio VD, Zhang J, Gesualdo C, Corte MD, Chan CC, Fielding Hejtmancik J, Simonelli F.

Ophthalmic Genet. 2011 Jun;32(2):118-21. doi: 10.3109/13816810.2011.559653. Epub 2011 Mar 8.

6.

Distributed changes in default-mode resting-state connectivity in multiple sclerosis.

Bonavita S, Gallo A, Sacco R, Corte MD, Bisecco A, Docimo R, Lavorgna L, Corbo D, Costanzo AD, Tortora F, Cirillo M, Esposito F, Tedeschi G.

Mult Scler. 2011 Apr;17(4):411-22. doi: 10.1177/1352458510394609. Epub 2011 Jan 14.

PMID:
21239414
7.

Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.

Costagliola C, Romano M, Corte MD, Perrotta R, Menzione M, Rinaldi M, Semeraro F, Parmeggiani F.

Retina. 2009 Oct;29(9):1227-34. doi: 10.1097/IAE.0b013e3181b773e1.

PMID:
19934817
8.

Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast.

Corte MD, González LO, Junquera S, Bongera M, Allende MT, Vizoso FJ.

J Cancer Res Clin Oncol. 2010 May;136(5):745-50. doi: 10.1007/s00432-009-0713-2. Epub 2009 Nov 7.

PMID:
19898865
9.

Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

Hum Pathol. 2009 Sep;40(9):1224-33. doi: 10.1016/j.humpath.2008.12.022. Epub 2009 May 12.

PMID:
19439346
10.

AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1).

Gargiulo A, Bonetti C, Montefusco S, Neglia S, Di Vicino U, Marrocco E, Corte MD, Domenici L, Auricchio A, Surace EM.

Mol Ther. 2009 Aug;17(8):1347-54. doi: 10.1038/mt.2009.112. Epub 2009 May 12.

11.

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma.

Altadill A, Rodríguez M, González LO, Junquera S, Corte MD, González-Dieguez ML, Linares A, Barbón E, Fresno-Forcelledo M, Rodrigo L, Vizoso FJ.

Dig Liver Dis. 2009 Oct;41(10):740-8. doi: 10.1016/j.dld.2009.01.016. Epub 2009 Apr 16.

PMID:
19372066
12.

Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.

Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Viña A, Rodriguez JC, Lamelas ML, Vizoso F.

Histopathology. 2008 Oct;53(4):403-15. doi: 10.1111/j.1365-2559.2008.03136.x.

PMID:
18983606
13.

Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.

Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2.

PMID:
18768247
14.

Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.

Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Alvarez AC, Rodriguez JC, Lamelas ML, Vizoso FJ.

BMC Cancer. 2008 May 28;8:149. doi: 10.1186/1471-2407-8-149.

15.

Relationship between arterial vascular calcifications seen on screening mammograms and biochemical markers of endothelial injury.

Pidal D, Sánchez Vidal MT, Rodríguez JC, Corte MD, Pravia P, Guinea O, Pidal I, Bongera M, Escribano D, González LO, Díez MC, Venta R, Vizoso FJ.

Eur J Radiol. 2009 Jan;69(1):87-92. Epub 2007 Oct 22.

PMID:
17945451
16.

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.

González LO, Pidal I, Junquera S, Corte MD, Vázquez J, Rodríguez JC, Lamelas ML, Merino AM, García-Muñiz JL, Vizoso FJ.

Br J Cancer. 2007 Oct 8;97(7):957-63. Epub 2007 Sep 11.

17.

Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.

del Casar JM, Corte MD, Alvarez A, García I, Bongera M, González LO, García-Muñiz JL, Allende MT, Astudillo A, Vizoso FJ.

J Cancer Res Clin Oncol. 2008 Feb;134(2):153-61. Epub 2007 Jul 13.

PMID:
17628829
18.

Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma.

Vizoso FJ, Rodriguez M, Altadill A, González-Diéguez ML, Linares A, González LO, Junquera S, Fresno-Forcelledo F, Corte MD, Rodrigo L.

World J Gastroenterol. 2007 Jun 21;13(23):3221-7.

19.

Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.

Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.

Histopathology. 2007 Jun;50(7):866-74.

PMID:
17543076
20.

Study of matrix metalloproteinases and their inhibitors in breast cancer.

Vizoso FJ, González LO, Corte MD, Rodríguez JC, Vázquez J, Lamelas ML, Junquera S, Merino AM, García-Muñiz JL.

Br J Cancer. 2007 Mar 26;96(6):903-11. Epub 2007 Mar 6.

21.

The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis.

Ildefonso C, Vazquez J, Guinea O, Perez A, Fernandez A, Corte MD, Junquera S, Gonzalez LO, Pravia P, Garcia-Moran M, Vizoso FJ.

Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):224-31. Epub 2006 Nov 22.

PMID:
17118521
22.

Prognostic value of pre-operative serum CA 15.3 levels in breast cancer.

Martín A, Corte MD, Alvarez AM, Rodriguez JC, Andicoechea A, Bongera M, Junquera S, Pidal D, Allende T, Muñiz JL, Vizoso F.

Anticancer Res. 2006 Sep-Oct;26(5B):3965-71.

23.

Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease.

Vizoso FJ, González LO, Corte MD, Corte MG, Bongera M, Martínez A, Martín A, Andicoechea A, Gava RR.

Scand J Gastroenterol. 2006 Sep;41(9):1050-5.

PMID:
16938718
24.

Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.

Carreño G, Del Casar JM, Corte MD, González LO, Bongera M, Merino AM, Juan G, Obregón R, Martínez E, Vizoso FJ.

Breast Cancer Res Treat. 2007 Mar;102(1):61-73. Epub 2006 Jul 19.

PMID:
16850244
25.

Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer.

Corte MD, González LO, Lamelas ML, Alvarez A, Junquera S, Allende MT, García-Muñiz JL, Argüelles J, Vizoso FJ.

Breast Cancer Res Treat. 2006 Jun;97(3):329-37. Epub 2006 May 10.

PMID:
16791488
26.

Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma.

Corte MD, Gonzalez LO, Corte MG, Quintela I, Pidal I, Bongera M, Vizoso F.

Int J Biol Markers. 2005 Oct-Dec;20(4):242-8.

PMID:
16398406
27.

Expression and prognostic value of EGFR in invasive breast cancer.

Quintela I, Corte MD, Allende MT, Vazquez J, Rodríguez JC, Bongera M, Lamelas M, Gonzalez LO, Vega A, García-Muñiz JL, Astudillo A, Vizoso F.

Oncol Rep. 2005 Dec;14(6):1655-63.

PMID:
16273272
28.

Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance.

Corte MD, Tamargo F, Alvarez A, Rodríguez JC, Vázquez J, Sánchez R, Lamelas ML, González LO, Allende MT, García-Muñiz JL, Fueyo A, Vizoso F.

Breast Cancer Res Treat. 2006 Mar;96(1):63-72. Epub 2005 Nov 3.

PMID:
16267614
29.

Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA).

Corte MD, Rodil JA, Vázquez J, García L, Rodríguez JC, Bongera M, Fernández JC, González LO, Lamelas ML, Allende M, García-Muñiz JL, Fueyo A, Vizoso FJ.

J Cancer Res Clin Oncol. 2005 Nov;131(11):701-14. Epub 2005 Nov 1.

PMID:
16075281
30.

Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.

Rodríguez J, Vázquez J, Corte MD, Lamelas M, Bongera M, Corte MG, Alvarez A, Allende M, Gonzalez L, Sánchez M, Vijande M, Garcia Muñiz J, Vizoso F.

Int J Biol Markers. 2005 Apr-Jun;20(2):103-11.

PMID:
16011040
31.

Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.

Rodrguez J, Vzquez J, Corte MD, Lamelas M, Bongera M, Corte MG, Alvarez A, Allende M, Gonzalez L, Snchez M, Vijande M, Garca-Muiz JL, Vizoso F.

Int J Biol Markers. 2005 Apr - Jun;20(2):103-111. doi: 10.5301/JBM.2008.679.

PMID:
28207136
32.

Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance.

Corte MD, Vérez P, Rodríguez JC, Roibás A, Domínguez ML, Lamelas ML, Vázquez J, García Muñiz JL, Allende MT, González LO, Fueyo A, Vizoso F.

Breast Cancer Res Treat. 2005 Mar;90(1):33-40.

PMID:
15770524
33.

Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance.

Vizoso FJ, Corte MD, Alvarez A, García I, del Casar JM, Bongera M, González LO, García-Muñiz JL, Allende MT.

Int J Biol Markers. 2004 Oct-Dec;19(4):268-74.

PMID:
15646832
34.

CD44s expression in resectable colorectal carcinomas and surrounding mucosa.

Fernández JC, Vizoso FJ, Corte MD, Gava RR, Corte MG, Suárez JP, García-Muñíz JL, García-Morán M.

Cancer Invest. 2004;22(6):878-85.

PMID:
15641486
35.

Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.

Vizoso FJ, Fernández JC, Corte MD, Bongera M, Gava R, Allende MT, García-Muñiz JL, García-Morán M.

J Cancer Res Clin Oncol. 2004 Nov;130(11):679-86. Epub 2004 Aug 6.

PMID:
15300427
36.

Significance of cytosolic hyaluronan levels in gastric cancer.

Vizoso FJ, del Casar JM, Corte MD, García I, Corte MG, Alvarez A, García-Muñiz JL.

Eur J Surg Oncol. 2004 Apr;30(3):318-24.

PMID:
15028316
37.

Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors.

Vizoso FJ, Fagilde MC, Corte MD, Corte MG, Gava R, Bongera M, Allende MT, García-Muñiz JL.

Int J Biol Markers. 2003 Oct-Dec;18(4):301-10.

PMID:
14756547
38.

Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.

García I, del Casar JM, Corte MD, Allende MT, García-Muñiz JL, Vizoso F.

Int J Biol Markers. 2003 Jul-Sep;18(3):200-6.

PMID:
14535591
39.

Apolipoprotein D expression in cutaneous malignant melanoma.

Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, Ordiz I, Merino AM.

J Surg Oncol. 2003 Jun;83(2):99-105.

PMID:
12772203
40.

Scleral buckling technique without retinopexy for treatment of rhegmatogeneous: a pilot study.

Figueroa MS, Corte MD, Sbordone S, Romano A, Alvarez MT, Villalba SJ, Schirru A.

Retina. 2002 Jun;22(3):288-93.

PMID:
12055461
41.

The abdominal aortic aneurysm sac after endoluminal exclusion: a medium-term morphologic follow-up based on volumetric technology.

Singh-Ranger R, McArthur T, Corte MD, Lees W, Adiseshiah M.

J Vasc Surg. 2000 Mar;31(3):490-500.

PMID:
10709062
42.

Effect of the anatomical structure of the arterial tree on the measurement of pulse wave velocity in man.

Corte MD, Locchi F, Spinelli E, Scarpelli PT.

Phys Med Biol. 1979 May;24(3):593-9. No abstract available.

PMID:
461518
43.

Application of a digital filter to biomedical signals.

Corte MD, Cerofolini O, Dubini S.

Med Biol Eng. 1974 May;12(3):374-7. No abstract available.

PMID:
4466997
44.

Rhythmic changes of the cutaneous pain threshold in man. A general review.

Procacci P, Corte MD, Zoppi M, Maresca M.

Chronobiologia. 1974 Jan-Mar;1(1):77-96. No abstract available.

PMID:
4459047
45.

On a mathematical model for the analysis of the glucose tolerance curve.

Corte MD, Romano S, Voeghelin MR, Serio M.

Diabetes. 1970 Jun;19(6):445-9. No abstract available.

PMID:
5421367
46.

[Reticulosarcoma of the stomach; report on two cases].

CORTE MD.

Riforma Med. 1957 Sep 21;71(38):1062-9. Italian. No abstract available.

PMID:
13495126

Supplemental Content

Loading ...
Support Center